PMID: 8474653Apr 1, 1993Paper

Risks of anticoagulation therapy after experimental corticectomy in the rat

Neurosurgery
V Laohaprasit, M R Mayberg

Abstract

To determine the optimal postoperative interval after which heparin therapy can be safely initiated, a rat model for experimental craniotomy and corticectomy was developed. In 50 rats (100 lesions), heparin therapy was initiated 1, 2, 3, 5, or 7 days after standardized bilateral frontal corticectomy and was continued for 7 days. Intraperitoneally administered heparin, 75 to 100 U/kg.h, was continuously given to maintain the activated partial thromboplastin time in one of two ranges: therapeutic (1.5-3 times control) or supratherapeutic (> 3 times control). The size of intracranial hemorrhage was determined from coronal brain sections by automated image analysis. No significant hemorrhage was observed in control (saline infusion) animals or in rats receiving therapeutic doses of heparin beginning more than 24 hours after surgery. Small (10-50 mm3) and large (> 50 mm3) hemorrhages were frequent at all intervals up to 5 days in animals with supratherapeutic activated partial thromboplastin time (P < 0.01). Judicious heparin therapy may be safely initiated at 48 hours after craniotomy and corticectomy in rats, whereas supratherapeutic anticoagulation is associated with intracranial hemorrhage at intervals of up to 5 days.

References

May 28, 1977·Lancet·M J MantM G Grace
Feb 1, 1979·American Heart Journal·J R Wilson, J Lampman
May 15, 1975·The New England Journal of Medicine·E W SalzmanR Rosenberg
Mar 1, 1975·Progress in Cardiovascular Diseases·G P Clagett, E W Salzman
Jan 1, 1986·Drugs·P Ockelford
Jan 1, 1986·Seminars in Thrombosis and Hemostasis·M N Levine, J Hirsh
Dec 1, 1986·Journal of the American College of Cardiology·S Wessler, S N Gitel
Jan 1, 1986·Haemostasis·D P ThomasA D Curtis
Oct 1, 1983·Angiology·H H KaufmanP L Gildenberg
Dec 1, 1984·Journal of Neurosurgery·K W Swann, P M Black
Apr 1, 1982·Neurosurgery·S K Powers, M S Edwards
Feb 1, 1980·Neurosurgery·J B Valladares, J Hankinson

❮ Previous
Next ❯

Citations

Jun 19, 2012·Translational Stroke Research·J Marc SimardVolodymyr Gerzanich
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David E GerberMichael B Streiff
May 16, 2006·British Journal of Neurosurgery·J CairdD Rawluk
Oct 9, 1999·Neurosurgery·B E Lazio, J M Simard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.